Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$187M Buy
1,431,324
+125,226
+10% +$14.7M 3.53% 8
2026
Q1
$157M Buy
+1,306,098
New +$151M 3.47% 9
2025
Q4
Sell
-608,720
Closed -$48.1M 128
2025
Q3
$48.1M Hold
608,720
1.17% 33
2025
Q2
$48.1M Buy
608,720
+150,304
+33% +$11.9M 1.17% 33
2025
Q1
$40.8M Sell
458,416
-14,259
-3% -$1.33M 1.21% 28
2024
Q4
$46.7M Buy
+472,675
New +$48.7M 1.09% 29

Other funds holding MRK

DJE Kapital's MRK Position: Q2 2026 in Review

DJE Kapital increased its Merck (MRK) stake by 9.6% in Q2 2026, buying an estimated $14.7M and bringing the position to 1,431,324 shares worth $187M. The position accounts for 3.53% of the portfolio, ranked #8.

DJE Kapital first reported a position in MRK in Q4 2024 and has held it in 6 quarters since. 3,824 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • DJE Kapital held 1,431,324 shares of Merck worth $187M as of Q2 2026.
  • DJE Kapital bought 125,226 Merck shares in Q2 2026, an estimated $14.7M.
  • Merck made up 3.53% of DJE Kapital's portfolio in Q2 2026, its #8 holding.
  • DJE Kapital first reported a position in Merck in Q4 2024 and has held it in 6 quarters since.
  • 3,824 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on DJE Kapital's 13F filing for Q2 2026, filed 4 Aug 2026.